. Author manuscript; available in PMC: 2011 Oct 1.

Published in final edited form as: J Hypertens. 2010 Oct;28(10):2076–2083. doi: 10.1097/HJH.0b013e32833c7a4d

Table 1.

Baseline characteristics of the study population by antihypertensive treatment group

Covariate	Chlorthalidone N=4318	Amlodipine N=2554	Lisinopril N=2437	P
Age, y	66.3±7	66.5±7	66.4±7	0.54
Gender, % females	1785 (41)	1117 (44)	1005 (41)	0.10
Race^*, n(%)
NHW	2301 (54)	1385 (54)	1311 (54)
NHB	1048 (24)	628 (25)	585 (24)
HW	600 (14)	333 (13)	323 (13)
HB	140 (3)	86 (3)	73 (3)
O	229 (5)	122 (5)	145 (6)	0.73
Current Smoking, %	1163 (27)	635 (25)	618 (25)	0.12
Baseline fasting glucose, mg/dL	93.4±11	93.3±11	93.8±11	0.26
Baseline BMI, kg/m²	29.0±6	28.8±6	28.8±6	0.34
Baseline SBP	144.6±14	144.2±14	144.8±14	0.31
Baseline DBP	83.9±10	83.7±10	83.9±10	0.40

non-Hispanic White (NHW), non-Hispanic Black (NHB), Hispanic White (HW), Hispanic Black (HB), Other (O)